Biological Antibacterials
Total Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
82
NCT04323475
Phage Therapy for the Prevention and Treatment of Wound Infections in Burned Patients
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 31, 2022
Completion: Aug 31, 2023
NCT04815798
Phage Therapy for the Prevention and Treatment of Pressure Ulcers.
Phase: Phase 1/2
Completion: Dec 31, 2023
NCT06456424
Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection
Role: Collaborator
Start: Nov 20, 2024
Completion: Nov 30, 2025
Loading map...